Baird Medical Investment Holdings Limited
NASDAQ:BDMDMedical - Devices
-$0.09 today
- Market cap
- $50.65M
- Beta
- -1.23
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$0.94
Volume 0.02M
Average 0.37M
BDMD Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Baird Medical Investment Holdings LimitedNASDAQ: BDMD
Other Non-Cash Items · Q4 FY2025 · quarter ended Dec 2025
Other non-cash items grows 128.4% year over year
Q4 FY2025 other non-cash items of $11.52M rose 128.4% year over year. Over 3 fiscal years it compounded at +26.8% a year.
Context
- Other non-cash items amounted to 3.9% of revenue in FY2025, up 0.6 pp from a year earlier.
- Other non-cash items increased in 2 of the last 3 fiscal years.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 884.64K USD
- Year-over-year change
- -29.0%
- 4-year CAGR
- +32.6%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 884.64K | -29.0% |
| FY2024 | 2024-12-31 | 1.25M | +12.8% |
| FY2023 | 2023-12-31 | 1.11M | +154.9% |
| FY2022 | 2022-12-31 | 433.58K | +51.6% |
| FY2021 | 2021-12-31 | 286.05K | — |
Other Non-Cash Items vs competitors
How BDMD compares with its peers on the latest reported figures
- BDMD's FY2025 other non-cash items of $884.64K is the 2nd largest of the 4 companies compared; the peer median is $842K.
- Its year-over-year change of -29.0% is the 2nd highest of 4, against a peer median of -57.1%.
- Other non-cash items amounts to 3.9% of revenue for BDMD, versus a peer median of 2.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.47M | -57.1% | -47.2% | 1.5% | |
BDMDBaird Medical Investment Holdings Limited | FY2025 | $884.64K | -29.0% | +26.8% | 3.9% |
| LTM Mar 2026 | $842K | +336.3% | +51.5% | 2.4% | |
OKUROnKure Therapeutics, Inc. | LTM Mar 2026 | $6K | -99.7% | — | — |
| Peer median (excluding BDMD) | $842K | -57.1% | +2.2% | 2.0% | |
Competitors are the stored peer set for BDMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 10.18M | 12.77M | 10.55M | 12.6M | (27.54M) |
| Depreciation & Amortization | 1.4M | 1.47M | 1.38M | 1.51M | 1.1M |
| Deferred Income Tax | (45.38K) | (143.32K) | 0 | 32.77K | (53.5K) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 17.47M |
| Change in Working Capital | (6.57M) | (14.05M) | (14.05M) | (21.7M) | 6.79M |
| Accounts Receivables | (3.49M) | (14.1M) | (9.67M) | (17.8M) | 5.35M |
| Inventory | (2.2M) | 1.57M | 113.66K | (187.54K) | 260.28K |
| Accounts Payables | 274.31K | (100.93K) | 0 | 727.8K | 483.95K |
| Other Working Capital | (1.15M) | (1.41M) | (4.49M) | (4.44M) | 698.51K |
| Other Non-Cash Items | 286.05K | 433.58K | 1.11M | 1.25M | 884.64K |
| Operating Cash Flow | 5.26M | 485.97K | (1.02M) | (6.31M) | (1.34M) |
| Capital Expenditures | (1.39M) | (5.95M) | (2.64M) | (2.85M) | (42.32K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 561 | (12.16K) | 0 | 0 | 0 |
| Investing Cash Flow | (1.39M) | (5.92M) | (2.64M) | (2.85M) | (42.32K) |
| Debt Repayment | (88.58K) | 4.46M | 2.35M | 10.31M | (2.16M) |
| Common Stock Issued | 0 | 0 | 0 | 2.9M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (5.43M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.59M | (46.4K) | 1.11M | (2.49M) | 763.62K |
| Financing Cash Flow | (1.93M) | 4.41M | 3.46M | 10.72M | (1.39M) |
| Effect of Forex Changes | 0 | (297.65K) | (3.11K) | (94.27K) | 375.79K |
| Net Change in Cash | 1.96M | (1.32M) | (200.44K) | 1.46M | (2.4M) |
| Free Cash Flow | 3.87M | (5.47M) | (3.66M) | (9.17M) | (1.39M) |
Baird Medical Investment Holdings Limited
NASDAQ:BDMD
Intrinsic Alpha fair value
Locked
Current Price
$1.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.